Bladder cancer (BCa) is the predominant malignancy of the urinary system. Herein, a
comprehensive urine proteomic feature was initially established for the noninvasive …

Background Bladder cancer is a common malignant tumor of the urinary system. The
progression of the condition is associated with a poor prognosis, so it is necessary to identify …

Urine is an ideal material to study the cancer-related protein biomarkers in bladder, whereas
exploration to these candidates is confronting technique challenges. Herein, we propose a …

Bladder cancer is the fourth most common cancer in men, and most cases are non-muscle-
invasive. A high recurrence rate is a critical problem in non-muscle-invasive bladder cancer …

Bladder cancer (BC) is the fifth most common cancer with a high prevalence rate. It is
classically classified in two groups, namely non-muscle invasive (NMIBC) and muscle …

Non-muscle-invasive bladder cancer (NMIBC) is one of the most common malignant tumors
in the urological system with a high risk of recurrence, and effective non-invasive biomarkers …

Urothelial bladder cancer (UBC) is a heterogeneous multifactorial malignancy with a high
recurrence rate. Current procedures for UBC diagnosis suffering from the lack of clinical …

The ability to detect and monitor bladder cancer in noninvasively obtained urine samples is
a major goal. While a number of protein biomarkers have been identified and commercially …

At present, proteomic methods have successfully identified potential biomarkers of
urological malignancies, such as prostate cancer (PC), bladder cancer (BC), and renal cell …

Bladder cancer is the most common cancer of the urinary tract and can be avoided through
proper surveillance and monitoring. Several genetic factors are known to contribute to the …